Emanuel Krebs
Emanuel Krebs
Health Economist & PhD student in the Faculty of Health Sciences, Simon Fraser University
Verified email at bccfe.ca
Title
Cited by
Cited by
Year
Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users
L Wang, JE Min, E Krebs, E Evans, D Huang, L Liu, YI Hser, B Nosyk
International Journal of Drug Policy 49, 32-40, 2017
322017
Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study
B Nosyk, X Zang, JE Min, E Krebs, VD Lima, MJ Milloy, J Shoveller, ...
The lancet HIV 4 (7), e303-e310, 2017
302017
The costs of crime during and after publicly funded treatment for opioid use disorders: a population‐level study for the state of California
E Krebs, D Urada, E Evans, D Huang, YI Hser, B Nosyk
Addiction 112 (5), 838-851, 2017
24*2017
Cost-effectiveness of publicly funded treatment of opioid use disorder in California
E Krebs, B Enns, E Evans, D Urada, MD Anglin, RA Rawson, YI Hser, ...
Annals of internal medicine 168 (1), 10-19, 2018
222018
Dynamics in the costs of criminality among opioid dependent individuals
E Krebs, T Kerr, J Montaner, E Wood, B Nosyk
Drug and alcohol dependence 144, 193-200, 2014
222014
The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study
A Borquez, L Beletsky, B Nosyk, SA Strathdee, A Madrazo, D Abramovitz, ...
The Lancet Public Health 3 (9), e429-e437, 2018
212018
Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs?
B Nosyk, E Krebs, O Eyawo, JE Min, R Barrios, JSG Montaner
Current HIV/AIDS Reports 11 (4), 468-478, 2014
202014
Ending the epidemic in America will not happen if the status quo continues: modeled projections for human immunodeficiency virus incidence in 6 US cities
B Nosyk, X Zang, E Krebs, JE Min, CN Behrends, C Del Rio, ...
Clinical Infectious Diseases 69 (12), 2195-2198, 2019
182019
Developing a dynamic HIV transmission model for 6 US cities: an evidence synthesis
E Krebs, B Enns, L Wang, X Zang, D Panagiotoglou, C Del Rio, ...
PloS one 14 (5), e0217559, 2019
182019
The Impact of Localized Implementation: Determining the Cost-Effectiveness of HIV Prevention and Care Interventions Across Six United States Cities
E Krebs, X Zang, B Enns, JE Min, C Behrends, C Del Rio, JC Dombrowski, ...
AIDS 34 (3), 447-458, 2020
172020
Ending the HIV epidemic in the USA: an economic modelling study in six cities
B Nosyk, X Zang, E Krebs, B Enns, JE Min, CN Behrends, C Del Rio, ...
The Lancet HIV 7 (7), e491-e503, 2020
142020
Development and calibration of a dynamic HIV transmission model for 6 US cities
X Zang, E Krebs, JE Min, A Pandya, BDL Marshall, BR Schackman, ...
Medical Decision Making 40 (1), 3-16, 2020
142020
The cost-effectiveness of human immunodeficiency virus testing and treatment engagement initiatives in British Columbia, Canada: 2011–2013
B Nosyk, JE Min, E Krebs, X Zang, M Compton, R Gustafson, R Barrios, ...
Clinical Infectious Diseases 66 (5), 765-777, 2018
122018
“Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic
B Nosyk, E Krebs, X Zang, M Piske, B Enns, JE Min, CN Behrends, ...
Clinical Infectious Diseases 71 (11), 2968-2971, 2020
112020
Estimating state transitions for opioid use disorders
E Krebs, JE Min, E Evans, L Li, L Liu, D Huang, D Urada, T Kerr, YI Hser, ...
Medical Decision Making 37 (5), 483-497, 2017
112017
Increased drug use and the timing of social assistance receipt among people who use illicit drugs
E Krebs, L Wang, M Olding, K DeBeck, K Hayashi, MJ Milloy, E Wood, ...
Social Science & Medicine 171, 94-102, 2016
112016
The costs of crime associated with stimulant use in a Canadian setting
B Enns, E Krebs, K DeBeck, K Hayashi, MJ Milloy, L Richardson, E Wood, ...
Drug and alcohol dependence 180, 304-310, 2017
102017
Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study
L Wang, E Krebs, JE Min, WC Mathews, A Nijhawan, C Somboonwit, ...
The Lancet HIV 6 (8), e531-e539, 2019
92019
Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder
E Krebs, T Kerr, E Wood, B Nosyk
Journal of substance abuse treatment 67, 30-37, 2016
92016
Structural design and data requirements for simulation modelling in HIV/AIDS: a narrative review
X Zang, E Krebs, L Wang, BDL Marshall, R Granich, BR Schackman, ...
PharmacoEconomics 37 (10), 1219-1239, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20